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pared with growth on plastic, cell culture on collagen-coatedTransforming growth factor-b regulates tubular epithelial-
plates showed a threefold increase in the percentage of cellsmyofibroblast transdifferentiation in vitro.
expressing a-SMA in response to TGF-b1.Background. We recently found evidence of tubular epithe-
Conclusion. TGF-b1 is a key mediator that regulates, in alial-myofibroblast transdifferentiation (TEMT) during the de-
dose-dependent fashion, transdifferentiation of tubular epithe-velopment of tubulointerstitial fibrosis in the rat remnant kid-
lial cells into a-SMA1 myofibroblasts. This transdifferentia-ney. This study investigated the mechanisms that induce TEMT
tion is markedly enhanced by growth on collagen type I. Thesein vitro.
findings have identified a novel pathway that may contributeMethods. The normal rat kidney tubular epithelial cell line
to renal fibrosis associated with overexpression of TGF-b1(NRK52E) was cultured for six days on plastic or collagen type
within the diseased kidney.I-coated plates in the presence or absence of recombinant trans-
forming growth factor-b1 (TGF-b1). Transdifferentiation of
tubular cells into myofibroblasts was assessed by electron mi-
croscopy and by expression of a-smooth muscle actin (a-SMA)
Tubulointerstitial fibrosis is considered to be the com-and E-cadherin.
mon final pathway leading to end-stage renal failure,Results. NRK52E cells cultured on plastic or collagen-coated
plates showed a classic cobblestone morphology. Culture in 1 irrespective of the nature of the initial renal injury. The
ng/ml TGF-b caused only very minor changes in morphology, process of tubulointerstitial fibrosis involves the loss of
but culture in 10 or 50 ng/ml TGF-b1 caused profound changes. renal tubules and the accumulation of extracellular ma-This involved hypertrophy, a loss of apical-basal polarity and
trix (ECM) proteins, such as collagen (types I, III, IV, V,microvilli, with cells becoming elongated and invasive, the for-
and VII), fibronectin, and laminin [1]. Although tubularmation of a new front-end back-end polarity, and the appear-
ance of actin microfilaments and dense bodies. These morpho- epithelial cells can synthesize a variety of ECM proteins
logical changes were accompanied by phenotypic changes. [2–4], it is thought that myofibroblasts are the main
Double immunohistochemistry staining showed that the addi- source of the increased ECM deposition seen in renaltion of TGF-b1 to confluent cell cultures caused a loss of
fibrosis and, indeed, in other types of tissue fibrosis [4–6].the epithelial marker E-cadherin and de novo expression of
The number of myofibroblasts identified by the expres-a-SMA. An intermediate stage in transdifferentiation could
be seen with hypertrophic cells expressing both E-cadherin sion of the a isoform of smooth muscle actin (a-SMA)
and a-SMA. De novo a-SMA expression was confirmed by is the best prognostic indicator of disease progression in
Northern blotting, Western blotting, and flow cytometry. In both human and experimental glomerulonephritis [7–14].particular, cells with a transformed morphology showed strong
Therefore, it is crucial to understand the origin of myofi-a-SMA immunostaining of characteristic microfilament struc-
broblasts and how myofibroblast production of ECMtures along the cell axis. There was a dose-dependent increase
in the percentage of cells expressing a-SMA with increasing proteins is regulated.
concentrations of TGF-b1, which was completely inhibited by We know little of the origin of myofibroblasts within
the addition of a neutralizing anti–TGF-b1 antibody. Com- the injured kidney. It had been suggested that interstitial
myofibroblasts may derive from the differentiation of
fibroblasts, the migration of perivascular smooth muscleKey words: TGF-b, transdifferentiation, collagen type 1, a-smooth
muscle actin, fibrosis, tubulointerstitial fibrosis. cells or local proliferation [12, 15–17]. Another possibil-
ity, suggested by two recent studies, is that tubular epi-Received for publication August 11, 1998
thelial cells can transdifferentiate into myofibroblasts un-and in revised form May 11, 1999
Accepted for publication May 19, 1999 der pathological conditions. Strutz et al showed that
tubular epithelial cells can express fibroblast-specific 1999 by the International Society of Nephrology
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protein 1 (Fsp1), a fibroblast marker, in a mouse model plates (Greiner Labortechnik, Frickenhausen, Germany),
four-chamber glass slides, or Thermanox plastic coverof antitubular basement membrane disease [18]. In addi-
tion, we have found phenotypic and ultrastructural evi- slips (Nunc, Naperville, IL, USA). In some experiments,
the culture plates, slides, or cover slips were coated withdence of transdifferentiation of tubular epithelial cells
into a-SMA1 myofibroblasts in the rat remnant kidney collagen type I (cat #150026; ICN Pharmaceuticals Inc,
Costa Mesa, CA, USA). To examine transdifferentia-[19]. However, the mechanism(s) regulating the process
of TEMT remains largely unknown. tion, cells were cultured for six days in the presence of 0,
1, 10 or 50 ng/ml recombinant human TGF-b (Promega,Transforming growth factor-b1 (TGF-b1), a multi-
functional cytokine with fibrogenic properties, has been Madison, WI, USA) with or without 5 or 10 mg/ml of
a neutralizing polyclonal rabbit anti–TGF-b1 antibodyimplicated in the pathogenesis of renal fibrosis in both
experimental and human glomerulonephritis [20]. This (Promega). During these experiments, the media were
changed after three days, at which point fresh TGF-b1is most clearly illustrated by the deliberate overexpres-
sion of TGF-b1 within the normal kidney, which induces and/or antibody were added.
fibrosis [21]. TGF-b stimulates ECM deposition by in-
Electron microscopycreasing the synthesis of ECM proteins on the one hand
while acting to inhibit their degradation on the other For scanning electron microscopy, cells were grown
[20]. In vitro, TGF-b has been shown to induce epithelial- on plastic cover slips, fixed in 2.5% glutaraldehyde in
mesenchymal transdifferentiation of mammary epithelial phosphate-buffered saline (PBS; pH 7.4) for 60 minutes,
cells and embryonic cardiac endothelial cells [22, 23]. rinsed with PBS, and dehydrated through graded ethanol
Furthermore, TGF-b has been shown to stimulate colla- (50, 75, 95, 100% for 10 min each). Cells then were trans-
gen synthesis and induce expression of Fsp1 by cultured ferred to amyl acetate for 10 minutes, put on critical point
mouse renal proximal tubular epithelial cells [24]. These drying, and then coated with gold. Cells were viewed in
studies suggest that TGF-b may be an important inducer a scanning electron microscope (Hitachi S-2300).
of epithelial-mesenchymal transdifferentiation. Transmission electron microscopy followed a pre-
In this study, we examined the ability of TGF-b1 to viously described protocol [27], with some modifications.
induce transdifferentiation of the normal rat tubular epi- Cells were grown on cover slips fixed in 2.5% glutaralde-
thelial cell line (NRK52E) into cells with phenotypic and hyde in PBS (pH 7.4), postfixed with 1% osmium tetrox-
ultrastructural characteristics of myofibroblasts. ide for 60 minutes, dehydrated through graded alcohols,
cut into small pieces, and embedded in Epon-Araldite.
Ultrathin sections were stained with uranyl acetate and
METHODS lead citrate and were examined in a Philips CM12 elec-
Cell culture tron microscope.
The well-characterized normal rat kidney epithelial
Northern blot analysiscell line (NRK52E) was obtained from the American
Type Culture Collection (Rockville, MD, USA). This A 1068 bp cDNA fragment of rat vascular smooth
muscle a-actin [28] was amplified by the polymerasecell line was used in preference to primary cultures of
tubular epithelial cells in order to avoid potential fibro- chain reaction and cloned using the pMOSBlue T-vector
kit (Amersham International, Buckinghamshire, UK).blast contamination. NRK52E cells are thought to be of
proximal tubular origin because they have a profile of A 358 bp cRNA riboprobe for rat glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as a con-collagen production consistent with proximal tubular
cells, and they secrete C-type natriuretic peptide and trol. Antisense digoxigenin (DIG)-labeled cRNA probes
were prepared using a T7 RNA polymerase kit (Boeh-express receptors for epidermal growth factor (EGF),
but do not express EGF itself [3, 25, 26]. NRK52E cells ringer Mannheim GmbH, Mannheim, Germany). Probes
were precipitated, and incorporation of DIG was deter-were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; with 4.5 g/liter glucose; Sigma Chemical Co, mined by dot blotting.
NRK52E cells were grown in collagen-coated six-wellSt. Louis, MO, USA) containing 1% fetal calf serum
(FCS) at 378C in a 5% CO2 atmosphere in six-well plastic plates with or without TGF-b1 or anti–TGF-b1 antibody.
c
Fig. 1. Phase contrast microscopy showing fibroblast-like morphological changes in cultured NRK52E tubular epithelial cells. (A) Cells cultured
in medium alone maintained a classic cobblestone epithelial morphology and growth pattern. Cells cultured for six days with 10 ng/ml transforming
growth factor-b1 (TGF-b1) (B), and more notably with 50 ng/ml TGF-b1 (C), exhibited marked hypertrophy, became elongated, and developed
a highly invasive growth pattern. (D) The morphological changes induced by 50 ng/ml TGF-b1 were blocked by the addition of 10 mg/ml of a
neutralizing anti–TGF-b1 antibody (magnification 3100).
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Expression of a-SMA mRNA was analyzed by Northern 1% normal goat serum and 1% FCS. The blot was then
developed using the ECL detection kit (Amersham) toblotting as described previously [29]. Cells were har-
vested by brief trypsinization and RNA extracted using produce a chemiluminescence signal that was captured
on x-ray film. Three experiments were performed.RNAzol (GIBCO BRL, Gaithersburg, MD, USA). Fif-
teen microgram samples were denatured with glyoxal
Flow cytometryand dimethylsulfoxide, size fractionated on 1.2% agarose
gels, and capillary blotted onto positively charged nylon A technique developed for the detection of intracellu-
lar antigens [31] was used to detect a-SMA within trans-membranes (Boehringer Mannheim). Membranes were
hybridized overnight at 688C with DIG-labeled a-SMA formed NRK52E cells. NRK52E cells were grown in
the presence or absence of TGF-b, harvested by briefor GAPDH cRNA probes in DIG Easy Hyb (Boehringer
Mannheim). Following hybridization, membranes were trypsinization, washed in cold PBS, fixed in 2% para-
formaldehyde in PBS for 30 minutes on ice followedwashed finally in 0.1 3 standard saline citrate (SSC)/
0.1% sodium dodecyl sulfate (SDS) at 688C. Bound by permeabilization with 0.2% saponin (Sigma) for 10
minutes. After washing, cells were stained with the 1A4probes were detected using sheep anti-DIG antibody
(Fab) conjugated with alkaline phosphatase and devel- anti–a-SMA mAb (1:2000) or an isotype control mAb
73.5 (antihuman CD45R antigen) for 20 minutes in 0.2%opment with CPD-star enhanced chemiluminescence
(Boehringer Mannheim). Chemiluminescence emissions saponin and washed and then labeled with FITC-conju-
gated goat antimouse IgG for 15 minutes in 0.2% sapo-were captured on Kodak XAR film, and densitometry
analysis was performed using the Gel-Pro Analyzer pro- nin. All samples were analyzed on an MoFlo cytometer
connected to a CICERO data acquisition system (Cyto-gram (Media Cybernetics, Silver Spring, MD, USA).
Two experiments were performed. mation, Fort Collins, CO, USA). Fluorescence histo-
grams of at least 5000 counts were generated from a gate
Western blot analysis set in the forward angle versus 908 light scatter scat-
tergram. The percentage of positive cells was measuredNRK52E cells were grown in collagen-coated six-well
plates with or without TGF-b1 or anti–TGF-1 antibody. from a cut-off set using the isotype-matched nonspecific
control antibody, whereas the mean channel fluores-Expression of a-SMA protein in cell lysates was analyzed
by Western blotting as previously described [30]. Cells cence (MCF) was measured over the entire distribution.
Data are expressed as the percentage of a-SMA1 cellswere washed in PBS and then lyzed in 1 ml of 1% Noni-
det P-40, 25 mm Tris-HCl, 150 mm NaCl, 10 mm ethylene- or the intensity of the MCF 6 sem from five experiments.
diaminetetraacetic acid (EDTA), pH 8.0, containing a 1
Immunohistochemistryin 50 dilution of a protease inhibitor cocktail (P2714;
Sigma) for 30 minutes on ice. Samples were centrifuged NRK52E cells were cultured in four-chamber glass
slides with or without collagen coating in the presenceat 14,000 g for five minutes to pellet cell debris. Samples
(20 mg) were mixed with a SDS-polyacrylamide gel elec- or absence of TGF-b, and were stained with monoclonal
antibodies (mAbs) to a-SMA or E-cadherin (C37020;trophoresis sample buffer, boiled for five minutes, electro-
phoresed on a 10% SDS polyacrylamide gel and elec- Transduction Laboratories, Lexington, KY, USA) using
one- or two-color immunohistochemistry, as previouslytroblotted onto Hybond-ECL nitrocellulose membrane
(Amersham International). The membrane was blocked described [19]. Cells were rinsed in PBS, fixed in 2%
paraformaldehyde, and preincubated with 10% FCS andin PBS containing 5% skimmed milk powder, 1% FCS,
and 0.02% Tween 20 and was then incubated for one hour 10% normal sheep serum to block nonspecific binding
and were then incubated with the 1A4 anti–a-SMA orwith 1 mg/ml of 1A4 anti–a-SMA mAb (Sigma) diluted
in the previously mentioned buffer. After washing, the irrelevant isotype control mAb (73.5) for 60 minutes.
After washing with PBS, endogenous peroxidase wasmembrane was incubated with a 1:20,000 dilution of per-
oxidase-conjugated goat antimouse IgG in PBS containing inactivated by incubation in 0.3% H2O2 in methanol for
c
Fig. 2. Scanning electron microscopy showing tubular epithelial-myofibroblast transdifferentiation (TEMT). NRK52E cells were cultured for six
days on collagen-coated cover slips in the presence or absence of TGF-b1. (A) Cells grown in medium alone show a normal aggregated epithelial
growth pattern with apical-basal polarity and many microvilli on the cell surface. (B) Culture in 1 ng/ml TGF-b1 showed partial, but incomplete,
transdifferentiation with the development of mild hypertrophy associated with an elongated morphology and a partial loss of microvilli on the
cell surface (*). (C–E) Culture in 50 ng/ml TGF-b1 induces complete tubular epithelial-myofibroblast transdifferentiation. Cells with a loss of
apical-basal polarity, loss of microvilli, development of a highly elongated morphology, and the presence of a disaggregated and invasive growth
pattern is shown in (C). The new front-end, back-end morphology with many cytoplasmic projections spreading from the new front end of cells
is shown in (D). A typical example of a transformed cell with marked hypertrophy, an elongated shape, and exhibiting a new front-end, back-end
morphology with complete loss of cell-surface microvilli is shown in (E). (F ) The addition of 10 mg/ml of a neutralizing anti–TGF-b1 antibody
abrogates the morphological changes induced by 50 ng/ml TGF-b1. F, front-end.
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20 minutes, incubated sequentially with peroxidase-con- and had many microvilli on the cell surface (Figs. 2A and
3A). There was no evidence of actin-like microfilamentsjugated goat antimouse IgG and peroxidase-conjugated
anti-peroxidase complexes (PAP), followed by develop- within these cells (Fig. 3A).
The culture of NRK52E cells in the presence of TGF-b1ment with diaminobenzidine to produce a brown color.
To block antibody cross-reactivity and facilitate antigen for six days induced a clear fibroblast-like morphology.
These changes were particularly marked when cells wereretrieval, sections were treated with 10 minutes of micro-
wave oven heating in 10 mm sodium citrate, pH 6.0, at grown on collagen-coated plates or slides and were dose
dependent (Figs. 1 B, C and 2 B, C). Culture in 1 ng/ml2450 MHz and 800 W power. After microwave treatment
and preincubation as described earlier here, sections TGF-b1 caused no change in NRK52E cell morphology
by phase contrast microscopy (data not shown). How-were then incubated with the anti–E-cadherin or control
mAb for 60 minutes, followed by alkaline phosphatase- ever, scanning electron microscopy showed the presence
of occasional cells exhibiting mild hypertrophy and start-conjugated goat antimouse IgG and alkaline phos-
phatase-conjugated anti-alkaline phosphatase complexes ing to develop a spindle-like shape, but which retained
epithelial polarity and microvilli (Fig. 2B). Culture of(APAAP). Finally, sections were developed with Fast
Blue BB Base (Sigma Chemical Co.). Cells were counter- NRK52E cells in 10 ng/ml TGF-b1 induced profound
morphological changes, with cells developing markedstained with hematoxylin and cover slipped in an aque-
ous mounting medium. All procedures were performed hypertrophy, becoming elongated, and losing the cobble-
stone growth pattern (Fig. 1B). The number of cells under-at room temperature.
For quantitative analysis of a-SMA and E-cadherin going morphological transformation was further in-
creased when TGF-b1 was added at a dose of 50 ng/mlexpression, NRK52E cells were cultured for six days in
six-well plastic plates with or without collagen coating. (Fig. 1C). Scanning electron microscopy showed that the
transformed cells completely lost epithelial polarity andCells were then harvested by brief trypsinization and
fixed in 2% paraformaldehyde, and cell spots were pre- microvilli on the cell surface. They became elongated,
disassociated with neighboring cells, and were highlypared on silanated slides. Immunoperoxidase staining
with the mAbs was performed as described earlier in invasive with many cytoplasmic projections (Fig. 2C).
The transformed cells also developed a new front-endthis study.
back-end fibroblast-like polarity, with many cytoplasmic
Quantitation of immunohistochemical staining projections present at the new front end (Fig. 2 C–E).
Transmission electron microscopy demonstrated thatThe number of NRK52E cells stained with the anti–a-
SMA or anti–E-cadherin mAbs was determined by TGF-b1 induced differentiation of NRK52E cells into
cells of a typical myofibroblast morphology, with thecounting the number of positive-stained cells in a total
of at least 1000 cells under high power (3400) in each presence of large bundles of actin microfilaments and
dense bodies within the cytoplasm (Fig. 3C). These actincell spot. Data from five experiments are expressed as
the mean percentage 6 sem. For all analyses, the ob- microfilaments and dense bodies were seen along the
cell axis and within the cytoplasmic projections at theserver was blinded to the coded slides.
new front end of the transformed cells (Fig. 3 C, D).
Statistical analysis The ability of TGF-b1 to induce the transformation
of NRK52E cells was inhibited by the addition of a neu-Data obtained from this study were analyzed by one-
way analysis of variance using the Newman–Keuls Multi- tralizing anti–TGF-b1 antibody, with cells retaining epi-
thelial polarity, microvilli, tight junctions, a cobblestoneple Comparison Test from the Complete Statistical Anal-
ysis program (CSS; Statsoft, Tulsa, IL, USA). growth pattern, with no evidence of hypertrophy, an
elongated morphology, or actin microfilaments (Figs. 1F,
2F, and 3B).
RESULTS
Morphological demonstration of transforming growth Phenotypic demonstration of transforming growth
factor-b1 induced tubular epithelial-myofibroblastfactor-b1–induced tubular epithelial-myofibroblast
transdifferentiation by NRK52E cells transdifferentiation by NRK52E cells
Northern blot analysis showed a single, faint band forNRK52E cells cultured in six-well plates or four-cham-
ber glass slides produced a confluent monolayer with a a-SMA mRNA in cultures of NRK52E cell grown in
medium with 1% FCS on collagen-coated plates (Fig.cobblestone morphology. Growth of NRK52E cells on
collagen-coated plates, or slides, also produced a conflu- 4). The addition of TGF-b1 induced a dose-dependent
increase in a-SMA mRNA expression, with a maximalent monolayer of cells with a classical epithelial cobble-
stone morphology (Fig. 1A). Scanning and transmission sevenfold increase over unstimulated cells. This was a
specific response, as demonstrated by blockade with aelectron microscopy demonstrated that these cells had
a cubic or round-shape, displayed apical-basal polarity, neutralizing anti–TGF-b1 antibody (Fig. 4). Western
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Fig. 3. Transmission electron microscopy showing tubular epithelial-myofibroblast transdifferentiation (TEMT). NRK52E cells were cultured for
six days on collagen-coated cover slips in the presence or absence of TGF-b1. (A) Cells grown in medium alone show a normal epithelial morphology
with apical-basal polarity and many microvilli (arrowheads) on cell surface. (B) The addition of 10 mg/ml of a neutralizing antibody anti–TGF-b1
antibody almost completely blocked the morphological changes induced by 50 ng/ml of TGF-b1 (C and D). In particular, the NRK52E cells
maintained apical-basal polarity, microvilli on the cell surface (arrowheads), and tight junctions. (C and D) Cells grown in the presence of 50
ng/ml TGF-b1. (C) A cell in the early stage of transformation shows hypertrophy, an elongated morphology, and a loss of apical-basal polarity,
microvilli, and tight junctions. There are prominent bundles of actin microfilaments lying peripheral to the cytoplasm at the new front-end
(arrowheads) and back-end of the cell. (D) A cell at a later stage of transformation showing characteristic actin microfilament bundles (arrows)
with dense bodies (*) throughout the cytoplasm, forming microfilament-rich cytoplasmic projections at the front end of the cell. Magnifications
(A) 34800, (B and C) 34200, and (D) 318,300.
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Fig. 4. Northern blot analysis of a-smooth muscle actin (a-SMA)
mRNA expression by NRK52E cells. Cells were cultured for six days
in collagen-coated six-well plates in the presence of medium alone,
TGF-b1, or TGF-b1 plus a neutralizing anti–TGF-b1 antibody. The
blot was probed for a-SMA and GAPDH expression. The ratio of
a-SMA/GAPDH ratio is shown in the graph. This is one of two experi- Fig. 6. Flow cytometric analysis of a-SMA expression by NRK52E
ments that produced similar results. cells. Cells were cultured for six days in collagen-coated six-well plates
in the presence of medium alone, TGF-b1, or TGF-b1 plus a neutralizing
anti–TGF-b1 antibody. (A) The percentage and (B) the mean channel
fluorescence intensity (MCF) of a-SMA expression are shown. The
background fluorescence signal from the irrelevant control antibody
has been subtracted. Each bar represents the mean 6 sem from five
separate experiments. *P , 0.05; **P , 0.001 compared with cells
grown in medium alone; aP , 0.05.
c
Fig. 7. Combined phenotypic and morphologic demonstration of tubu-
lar epithelial-myofibroblast transdifferentiation (TEMT). NRK52E
cells were grown for six days on collagen-coated glass slides in the
presence or absence of TGF-b1. Cells expressing a-SMA protein were
detected by immunoperoxidase staining (brown) using the 1A4 mAb.
Fig. 5. Western blot analysis of a-smooth muscle actin (a-SMA) pro- (A) Cells cultured in medium alone show a normal epithelial morphol-
tein expression by NRK52E cells. Cells were cultured for six days in ogy with a cobblestone grown pattern. Only occasional cells stained
collagen-coated six-well plates in the presence of medium alone, TGF-b1, positive for a-SMA. (B) Culture in 50 ng/ml TGF-b1 induced TEMT.
or TGF-b1 plus a neutralizing anti–TGF-b1 antibody. A single band Most of the cells expressing a-SMA (brown stain) exhibited hypertro-
of approximately 43 kDa was detected. This is one of three experiments phy, an elongated morphology, a disaggregated and invasive growth
that gave similar results. pattern, and a new front-end back-end mesenchymal polarity. Further
examples of transformation are: (C) a cell in the early stage of transfor-
mation showing marked hypertrophy and numerous a-SMA1 myofil-
aments within the cytoplasm along the cell axis; (D) a transformed
blotting of cell lysates showed that TGF-b1 induced a cell showing a new front-end back-end polarity, with many a-SMA1
cytoplasmic projections at the new front-end; and (E) a highly elongated,dose-dependent increase in the expression of a-SMA
hypertrophic, and invasive myofibroblast showing strong a-SMA ex-protein in NRK52E cells, which was also inhibited by
pression. (F ) The addition of 10 mg/ml of a neutralizing anti–TGF-b1
the addition of a neutralizing antibody (Fig. 5). antibody completely blocked TEMT induced by 50 ng/ml TGF-b1.
Magnifications 3100 (A, B, and F), 3400 (C, D, and E).Flow cytometry of saponin-permeabilized NRK52E
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Fig. 8. Effect of collagen type I on TGF-b1 induced a-smooth muscle
Fig. 9. TGF-b1 induces a-smooth muscle actin expression by NRK52Eactin expression by NRK52E cells. Immunohistochemistry staining for
cells in a dose-dependent fashion. Immunohistochemistry staining fora-SMA expression was performed on NRK52E cells cultured for six
a-SMA expression was performed on NRK52E cells cultured for sixdays in plastic wells (h) or collagen-coated wells (j) with or without
days on collagen-coated wells in the presence of varying concentrations50 ng/ml TGF-b1. Each bar represents the mean percentage of
of TGF-b1 with or without a neutralizing anti–TGF-b1 antibody. Eacha-SMA–positive cells 6 sem from four separate experiments. ***P ,
bar represents the mean percentage of a-SMA–positive cells 6 sem0.001 compared with growth on plastic.
from four separate experiments. ***P , 0.001 compared with medium
alone; aP , 0.001 compared with 50 ng/ml TGF-b1.
cells was used to quantitate TGF-b1–induced a-SMA
a-SMA was also quantitated (Figs. 8 and 9). An interest-
protein expression. As shown in Figure 6 NRK52E cells ing observation was that NRK52E cells grown on colla-
grown in medium alone on collagen-coated plates exhib- gen-coated plates showed a threefold increase in the
ited a very weak expression of a-SMA protein. The addi- percentage of cells expressing a-SMA cells following
tion of TGF-b1 caused a dose-dependent increase in the TGF-b1 stimulation compared with cells grown on plas-
percentage of NRK52E cells expressing a-SMA, with tic plates (Fig. 8). TGF-b1 induced a dose-dependent
almost half (46.8 6 7%) of the cells being positive when increase in the percentage of NRK52E cells expressing
cultured in 50 ng/ml TGF-b1 (Fig. 6A). As well as in-
a-SMA, which was completely abrogated by the addition
creasing the percentage of NRK52E cells expressing of a neutralizing anti–TGF-b1 antibody (Figs. 7f and 9).
a-SMA protein, TGF-b1 caused a dose-dependent in- As a second phenotypic marker of TGF-b1–induced
crease in the intensity of a-SMA expression (Fig. 6B). transdifferentiation of NRK52E cells, we analyzed the
The ability of 50 ng/ml TGF-b1 to increase a-SMA pro- expression of the epithelial antigen E-cadherin. Conflu-
tein expression was almost completely abrogated by the ent cultures of NRK52E cells showed E-cadherin expres-
addition of a neutralizing antibody (Fig. 6). sion along the cell surface at tight junctions (Fig. 10a).
Immunohistochemistry staining was used to evaluate Culture of cells in 10 ng/ml TGF-b1 caused de novo
the morphology and number of NRK52E cells expressing expression of a-SMA in hypertrophic cells, many of
a-SMA protein. NRK52E cells cultured on plastic or which maintained E-cadherin expression (Fig. 10b). Cul-
collagen-coated surfaces showed a normal epithelial ture of cells in higher concentrations of TGF-b1 caused
morphology and cobblestone growth pattern, with only a more profound change in morphology, and these cells
occasional cells staining positive for a-SMA (Fig. 7A). showed strong a-SMA expression with a complete loss
Those NRK52E cells induced to transdifferentiate by of E-cadherin expression (Fig. 10c). Quantitation of the
TGF-b1, whether grown on plastic or collagen-coated percentage of a-SMA and E-cadherin positive cells after
surfaces, all exhibited strong a-SMA staining (Fig. 7 B–F). six days of culture in 50 ng/ml TGF-b1 showed a largely
The various elements of TGF-b1–induced transdifferen- reciprocal pattern of expression of these two markers
tiation could be seen in a-SMA–stained cells. For exam- (Fig. 11). These phenotypic changes were prevented by
ple, a-SMA–positive cells exhibited hypertrophy, an addition of a neutralizing anti–TGF-b1 antibody (Fig.
elongated morphology, and an invasive growth pattern 10d and 11).
(Fig. 7B). Transformed cells also showed strong a-SMA
staining in cytoplasmic myofilaments along the cell axis
DISCUSSIONand in the many cytoplasmic projects seen at the new
front end of cells with an invasive mesenchymal polarity This study provides evidence that TGF-b1 can induce
(Fig. 7 C–E). complete transdifferentiation of the normal rat tubular
epithelial cell line (NRK52E) into myofibroblasts on theThe number of NRK52E cells staining positive for
Fan et al: Role of TGF-b in TEMT 1465
Fig. 10. TGF-b1 induces loss of E-cadherin expression and de novo expression of a-SMA in NRK52E cells. Double immunostaining was used
to detect E-cadherin (blue) and a-SMA (brown). (a) Confluent, cobblestone cells in control medium showing E-cadherin (blue) expression in
tight junctions and no a-SMA expression. (b) Cells cultured for six days in 10 ng/ml TGF-b1 causes the induction of a-SMA and a loss of
E-cadherin expression. Indeed, many double-positive cells can be seen which also exhibit hypertrophy with an irregular growth pattern. (c) Cell
culture for six days in 50 ng/ml TGF-b1 causes a marked induction of a-SMA (brown) and a loss of E-cadherin expression by cells that have lost
the epithelial morphology, becoming large and elongated. Note that weak E-cadherin expression is maintained in untransformed cells that retain
a cobblestone pattern. (d) The addition of a neutralizing anti–TGF-b antibody inhibits the changes seen with 50 ng/ml TGF-b. Only occasional
a-SMA–positive cells are seen, whereas virtually all cells retain E-cadherin expression at tight junctions in cells with a cobblestone growth pattern.
Magnification 3200 (a–c), 3160 (d).
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the apparently contradictory results in the literature. For
example, a study by Creely et al found that NRK52E
cells cultured for five days in 3 ng/ml TGF-b1 caused no
change in the overall cobblestone pattern of cell growth
[3]. However, primary cultures of rabbit proximal tubu-
lar epithelial cells grown in 10 ng/ml TGF-b1 for 48 hours
did show marked transformation, with cells becoming
elongated, developing actin stress fibers, and forming
clusters of adherent cells [32, 33]. Interestingly, the use
of 3 ng/ml TGF-b1 caused partial, but not complete,
morphological transformation of the mouse proximal tu-
bular epithelial cell line [24]. Indeed, a combination of
EGF plus TGF-b1 was required to cause complete epi-
Fig. 11. Quantitation of E-cadherin and a-SMA expression following thelial-mesenchymal transdifferentiation, characterized
TGF-b1 addition to NRK52E cells. Double immunohistochemistry by spindle-shaped cells with stress fibers, a loss of epithe-
staining for E-cadherin and a-SMA expression was performed on
lial-specific antigens, and the expression of mesenchymalNRK52E cells cultured for six days on collagen-coated wells in the pres-
ence of varying concentrations of TGF-b1 with or without a neutralizing antigens Fsp1 and a-SMA [24]. It would be interesting
anti–TGF-b1 antibody. Symbols are: (h) medium; (j) TGF-b1; ( ) to know whether this additive effect is still evident when
TGF-b1 1 antibody. Each bar represents the mean percentage of posi-
using higher concentrations of TGF-b1.tive cells 6 sem from four separate experiments. ***P , 0.001 compared
with medium alone. A second important finding in this study was that cul-
ture of NRK52E cells on collagen type I-coated surfaces
enhanced TGF-b1–induced transdifferentiation, although
basis of ultrastructural morphology, de novo expression collagen coating in itself did not trigger transdifferentia-
of the mesenchymal marker, a-SMA, and the loss of tion. This is consistent with previous studies in which
expression of the epithelial marker E-cadherin. This pro- epithelial cell contacts with ECM proteins, such as colla-
cess is dose dependent and is substantially augmented gen type I, play an important role in the induction of
by cell growth on collagen type I. These in vitro studies the transdifferentiation process [34]. For example, ante-
lend support to recent reports describing the transdiffer- rior lens epithelium with an intact basement membrane
entiation of tubular epithelial cells into fibroblasts, or grown on top of collagen-coated plates retains a normal
myofibroblasts, in experimental kidney disease [18, 19]. epithelial morphology, but when these explants are
An important observation in this study was that TGF- grown within a three-dimensional collagen gel, the epi-
b1–induced transdifferentiation of NRK52E cells was thelial cells transform into fibroblast-like mesenchymal
dose dependent. This was not just a simple matter of cells [35]. Similarly, the culture of MCT proximal tubular
adding more TGF-b1 to get a larger number of cells to epithelial cells on collagen I-coated plates induces ex-
transdifferentiate, but there was a threshold concentra- pression of Fsp1, but not morphological transformation
tion of TGF-b1 that had to be reached in order to achieve [24], but when MCT cells or Madin-Darby canine tubular
complete transdifferentiation. This was illustrated by a epithelial cells are grown within three-dimensional colla-
culture of cells in 1 ng/ml TGF-b1 that induced a minor gen type I gels, they undergo transdifferentiation into
increase in a-SMA mRNA and protein expression but fibroblast-like mesenchymal cells [19, 36]. Consistent
failed to drive a complete morphological transformation. with these in vitro studies, we found that that the trans-
Indeed, phase-contrast microscopy of these cells showed differentiation of tubular epithelial cells into a-SMA1
little morphological change. However, electron micros- myofibroblasts in the rat remnant kidney was invariably
copy revealed that some cells had become elongated, associated with disruption of the tubular basement mem-
showed a partial loss of surface microvilli, and had devel- brane [19], suggesting that contacts between the tubular
oped a limited organization of stress fibers, but they did epithelial cell and interstitial ECM components promote
not achieve complete transdifferentiation in terms of TEMT in vivo.
developing a new front-end back-end polarity or an inva- In summary, this study demonstrated that TGF-b1 can
sive growth pattern. The development of complete mor- induce, in a dose-dependent fashion, the transdifferentia-
phological transformation of NRK52E cells required cul- tion of normal tubular epithelial cells into myofibroblasts
ture in 10 ng/ml TGF-b1. Increasing the concentration in vitro. The contact between epithelial cells and collagen
of TGF-b1 from 10 to 50 ng/ml increased the number type I markedly enhanced TGF-b1–driven TEMT, and
of cells undergoing transdifferentiation, without chang- this may be an important element of TEMT in vivo.
ing the morphology of the transformed cells. These findings have identified a novel pathway that may
The threshold concentration of TGF-b1 required to contribute to renal fibrosis associated with overexpres-
sion of TGF-b1 within the diseased kidney.drive TEMT may provide an explanation for some of
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